Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 8-K/A Current report
- 23.1 Consent of Horne LLP
- 99.1 Audited Financial Statements of Baymedica, Inc. for the Year Ended December 31, 2020
- 99.2 Unaudited Financial Statements of Baymedica, Inc. for the Nine Months Ended September 30, 2021
- 99.3 Unaudited Pro Forma Condensed Combined Financial Information of Inmed Pharmaceuticals Inc
- Download Excel data file
- View Excel data file
INM similar filings
- 10 Feb 22 Regulation FD Disclosure
- 19 Jan 22 InMed Launches Cannabicitran (CBT), Expanding its Rare Cannabinoid Portfolio for the Health and Wellness Sector
- 5 Jan 22 InMed Issues Annual Letter to Shareholders Highlighting Key Accomplishments from 2021 and Providing 2022 Outlook
- 22 Dec 21 Audited Financial Statements
- 20 Dec 21 InMed Announces Results of 2021 Annual General Meeting
- 23 Nov 21 Other Events
- 10 Nov 21 InMed Pharmaceuticals Reports First Quarter Fiscal 2022 Financial Results and Provides Business Update
Filing view
External links